Nebivolol Hydrochloride Tablet shortage
Nebivolol Hydrochloride Tablet is currently listed in shortage by the FDA. The FDA lists 16 affected products. This page was last refreshed from FDA data on Sep 28, 2026.
Torrent Pharmaceuticals is permanently stopping its generic nebivolol hydrochloride tablets. Bystolic (nebivolol hydrochloride) in all strengths is still listed by other manufacturers that have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Nebivolol Hydrochloride Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Mar 25, 2026Currently in shortage16 of 16 products affected.
-
Mar 25, 2026First reported to the FDA16 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Torrent Pharmaceuticals Limited 📞 908-280-3333 16 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-90) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-05) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-30) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-05) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-30) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-90) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-90) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-90) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-05) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-01) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-05) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-30) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Nebivolol Hydrochloride Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Nebivolol Hydrochloride Tablet? options further down this page.
Why is Nebivolol Hydrochloride Tablet in shortage?
Torrent Pharmaceuticals has decided to permanently stop making their version of nebivolol hydrochloride tablets. This affects all four strengths they made — the 2.5 mg, 5 mg, 10 mg, and 20 mg tablets — across all of their package sizes. They did not share a specific public reason for why they made this decision.
It's worth knowing that this applies only to Torrent's products. Because this is a permanent stop rather than a temporary supply hiccup, there is no expected recovery date for Torrent's nebivolol tablets.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Nebivolol Hydrochloride Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Nebivolol Hydrochloride Tablet?
Nebivolol hydrochloride tablets are currently on the FDA shortage list. This medicine is used to help control blood pressure, and I want to walk you through what this report means so you can plan ahead.
The report comes from one manufacturer, Torrent Pharmaceuticals, and it lists all four strengths — 2.5 mg, 5 mg, 10 mg, and 20 mg — as having no available source from that company. The reason given is that this maker is discontinuing production. Because this is a discontinuation rather than a temporary delay, this particular supply may not return. That said, this report reflects only one manufacturer, and other companies make the same medicine.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own — steady blood pressure control matters.
- Ask your pharmacy to check wholesalers and other makers. The same medicine (nebivolol, including the brand Bystolic) is still made by companies such as Allergan, Major Pharmaceuticals, Apnar Pharma, and Unichem, though it may not be in local stock right away.
- If your strength cannot be found, ask your prescriber or pharmacist about a suitable option.
Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls. This is general national data and may not match your pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Nebivolol Hydrochloride Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Nebivolol Hydrochloride Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Bystolic | NEBIVOLOL HYDROCHLORIDE 2.5 mg/1 | Tablet · Oral | Allergan, Inc. | 00456-1402-01 |
| Bystolic | NEBIVOLOL HYDROCHLORIDE 5 mg/1 | Tablet · Oral | Allergan, Inc. | 00456-1405-01 |
| Bystolic | NEBIVOLOL HYDROCHLORIDE 10 mg/1 | Tablet · Oral | Allergan, Inc. | 00456-1410-01 |
| Bystolic | NEBIVOLOL HYDROCHLORIDE 20 mg/1 | Tablet · Oral | Allergan, Inc. | 00456-1420-01 |
| Nebivolol | NEBIVOLOL 2.5 mg/1 | Tablet · Oral | Major Pharmaceuticals | 00904-7497-04 |
| Nebivolol | NEBIVOLOL 5 mg/1 | Tablet · Oral | Major Pharmaceuticals | 00904-7498-04 |
| Nebivolol | NEBIVOLOL 10 mg/1 | Tablet · Oral | Major Pharmaceuticals | 00904-7499-04 |
| Nebivolol | NEBIVOLOL HYDROCHLORIDE 2.5 mg/1 | Tablet · Oral | Apnar Pharma LP | 24689-0159-01 |
| Nebivolol | NEBIVOLOL HYDROCHLORIDE 5 mg/1 | Tablet · Oral | Apnar Pharma LP | 24689-0160-01 |
| Nebivolol | NEBIVOLOL HYDROCHLORIDE 10 mg/1 | Tablet · Oral | Apnar Pharma LP | 24689-0161-01 |
| Nebivolol | NEBIVOLOL HYDROCHLORIDE 20 mg/1 | Tablet · Oral | Apnar Pharma LP | 24689-0162-01 |
| Nebivolol Hydrochloride | NEBIVOLOL HYDROCHLORIDE 2.5 mg/1 | Tablet · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0375-05 |
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Nebivolol 2.5 mg | Lifestar | 30 tablets | $0.109 | AB | FDA listed |
| Nebivolol 5 mg | Major | 30 tablets | $0.113 | AB | Availability likely |
| nebivolol 5 mg | Apnar | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | Macleods | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | Solco | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | Aurobindo | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | American | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | ANI | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | Novadoz | 30 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | Modavar | 90 tablets | $0.113 | AB | Availability likely |
| Nebivolol 5 mg | NorthStar | 30 tablets | $0.113 | AB | Availability likely |
| nebivolol 5 mg | Torrent | 90 tablets | $0.113 | — | Discontinued |
| Nebivolol 2.5 mg | Major | 30 tablets | $0.117 | AB | Availability likely |
| nebivolol 2.5 mg | Apnar | 30 tablets | $0.117 | AB | Availability likely |
| Nebivolol 2.5 mg | Macleods | 30 tablets | $0.117 | AB | Availability likely |
| Nebivolol 2.5 mg | Solco | 30 tablets | $0.117 | AB | Availability likely |
| Nebivolol 2.5 mg | Aurobindo | 30 tablets | $0.117 | AB | Availability likely |
| Nebivolol 2.5 mg | ANI | 30 tablets | $0.117 | AB | Availability likely |
| Nebivolol 2.5 mg | Novadoz | 30 tablets | $0.117 | AB | Availability likely |
| Nebivolol 2.5 mg | NorthStar | 30 tablets | $0.117 | AB | Availability likely |
| nebivolol 2.5 mg | Torrent | 30 tablets | $0.117 | — | Discontinued |
| Nebivolol 5 mg | Lifestar | 30 tablets | $0.126 | AB | FDA listed |
| Nebivolol 10 mg | Major | 30 tablets | $0.141 | AB | Availability likely |
| nebivolol 10 mg | Apnar | 30 tablets | $0.141 | AB | Availability likely |
| Nebivolol 10 mg | Macleods | 30 tablets | $0.141 | AB | Availability likely |
| Nebivolol 10 mg | Solco | 30 tablets | $0.141 | AB | Availability likely |
| Nebivolol 10 mg | Aurobindo | 30 tablets | $0.141 | AB | Availability likely |
| Nebivolol 10 mg | American | 30 tablets | $0.141 | AB | Availability likely |
| Nebivolol 10 mg | ANI | 500 tablets | $0.141 | AB | Availability likely |
| Nebivolol 10 mg | Novadoz | 30 tablets | $0.141 | AB | Availability likely |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Nebivolol Hydrochloride Tablet — that fall in the same broad treatment class (beta-adrenergic blocking agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other cardiovascular shortages
Nebivolol Hydrochloride Tablet shortage FAQs
Is Nebivolol Hydrochloride Tablet in shortage?
Which products are affected?
When will Nebivolol Hydrochloride Tablet be available again?
Can I still get Nebivolol Hydrochloride somewhere?
What should I do if I take Nebivolol Hydrochloride Tablet?
Still have a question about the Nebivolol Hydrochloride Tablet shortage?
Ask a pharmacist about this shortage →View Nebivolol Hydrochloride Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.